TCGAThe Cancer Genome AtlasdasatinibButyratedocetaxelerlotinibgefitinibSTADstomach adenocarcinoma
…ated from the Gene Set Enrichment Analysis (GSEA) database. The TCGA cohort was partitioned into training and validation sets. Using…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 6,661–6,720 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
Papadopoulou et al.1Papworth Hospital1Paracelsus Medical University1Parc Taulí Hospital1Paris Cité University1Paris Transplant Group1Paris-Pavia Cohort1Parker Institute for Cancer Immunotherapy1Parker University1Parkinson’s Progression Markers Initiative1Parse Biosciences1Patan Hospital1Patel et al1Pathways1Pathways Study in Washington State1Pathways trial1Paul Lorigan1Pearce et al1Pediatr. Pulmonol. 20211Pediatric Cervical Spine Clearance Working Group1Pediatric Emergency Care Applied Research Network1Pediatric Health Information System1Pediatric Perioperative Outcomes Group1Pediatric Radiology1Pega et al1Peking Union Medical College Ethics Committee1Peking Union Medical College Hospital Institutional Review Board1Peking University Health Science Center1Peking University Institution Review Board1Peking University International Hospital1Peking University Sixth Hospital1Pelotonia Institute for Immuno-Oncology1Pembro-real 5Y registry1Peninsula Medical School1Penn Radiation Oncology1Penumbra1Penumbra Inc1Penumbra Scientific Advisory Board1Perceptive Robotics, Inc1Perelman School of Medicine1Perined1Perioperative Pain Service1Perkins et al.1Persson et al1Perth Longitudinal Study of Ageing Women1Perth Royal Infirmary1Perugia Infectious Diseases Day Hospital1Peruvian Department of Health1Peterloo Medical Centre1Pfizer-BioNTech1PhD nursing faculty1Phadia AB1PharmaPrinter1Pharmaceutical Care Department1Pharmaceutical company1Pharmacovigilance Centre1Pharmacy 20251Pharmacy Service1Pharmacy-Internal Medicine1Phase I Unit1
Articles mentioning institutions
11,350 articles · page 166 of 946NIH NCIThe Harvard Ludwig CenterDana-Farber Cancer Institutetrastuzumab deruxtecanHER2-low breast cancerSusan G. Komen FoundationHER2-lowBreast CancerHER2-0 tumors
…udwig Center, NIH DF/HCC SPORE in Breast Cancer (P50 CA168504), NIH NCI (R37 CA269499), and The Concern Foundation. A.N. is supported b…
University of HoustonNational Institutes of Healthgastric cancerPIK3CA-associated breast cancerlung cancerPPmGentriple-negative breast cancer
…ities (NIMHD) of the National Institutes of Health (NIH) to the University of Houston under Award Number U54MD015946. The content is solely the respo…
Weill Cornell Medical CollegeJ Exp MedOva257-264 SIINFEKLimmunotherapyImmunogenic tumorslung adenocarcinomasgp100/pmel 17
… approved by the institutional Animal Care and Use Committee at Weill Cornell Medical College (protocol no. 0806-762A).Abstract 1296 Figure 1Differential act…
RADIOHEADcommunity oncology clinicsPD-1 inhibitors
…uantify ~600 circulating proteins across ~3000 samples from the RADIOHEAD (Resistance Drivers for Immuno-Oncology Patients Interrogated b…
Samsung Medical CenterSeoul National University HospitalDiscovery Life Sciencesimmune checkpoint inhibitorICIimmunotherapy
…cimens from registry studies. Ethics approval was obtained from Samsung Medical Center (IRB No. 2022-05-050) and from Seoul National University Hospit…
TCGAThe Cancer Genome Atlasmelanoma
… expression signature associated with metastatic status in this TCGA cohort. However, due to limited sample size, the model’s genera…
The Cancer Genome AtlasTCGAHPAMESOmesotheliomaccRCCDLBCLClear cell renal cell carcinomaLUSCimmunotherapy
…herapeutic selectivity profile.Methods RNA sequencing data from The Cancer Genome Atlas (TCGA) encompassing 33 tumor types were analyzed to assess CD70…
The Cancer Genome AtlasTCGAmalignanciescheckpoint blockade
…cross diverse tumor types.Methods Bulk RNA sequencing data from The Cancer Genome Atlas (TCGA) Pan-Cancer cohort (n > 9,000) were analyzed. CD70 expres…
BioChain Institute Inc.BioChainHuman carcinoma
… sensitivity raise questions that are critical to their use. At BioChain Institute Inc. (BioChain), we are running a series of tests on Xenium v1 as we…
TCGAatezolizumabdocetaxelAB598carboplatinESCApaclitaxelPD-L1 low gastroesophageal tumors
…ve CROSS regimen.Conclusions While PD-L1 mRNA low GEC tumors in TCGA exhibit lower expression of DC lineage genes, ICD chemoradiothe…
95.3%
The Ohio State UniversityOhio State UniversityPancreatic Ductal Adenocarcinoma (PDAC)anti-cancer interventionsAssociation for Assessment and Accreditation of Laboratory Animal Care International
…d by the Institutional Animal Care and Use Committee (IACUC) at The Ohio State University (2009A0178-R5) and mice were treated in accordance with institu…